Literature DB >> 9497489

Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro.

C Schebesch1, V Kodelja, C Müller, N Hakij, S Bisson, C E Orfanos, S Goerdt.   

Abstract

We compared the immunological functions of interferon-gamma (IFN-gamma)-induced, classically activated macrophages (caM phi) and of interleukin-4 (IL-4)- and glucocorticoid-induced, alternatively activated macrophages (aaM phi) in a human co-culture system in vitro. Proliferation of peripheral blood leucocytes (PBL) or CD4+ T cells mediated by optimal doses of phytohaemagglutinin (PHA) or concanavalin A (Con A) was only marginally influenced by caM phi, but was strongly inhibited by aaM phi. The degree of lymphocyte proliferation sustained in the presence of caM phi was gradually reduced in a dose-dependent fashion by the addition of aaM phi. Flow cytometric analysis revealed that expression of costimulatory molecules such as CD11a, CD40, CD54, CD58, CD80 and CD86 did not vary significantly between caM phi and aaM phi and was low for CD58, CD80 and CD86. As shown by reverse transcriptase-polymerase chain reaction (RT-PCR) analysis, IL-10 was expressed in caM phi, aaM phi and control macrophages; the level of expression of IL-10 was slightly enhanced in aaM phi. Neither neutralizing anti-IL-10 antibodies, indomethacin nor NG-monomethyl-L-arginine (NMMLA) was able to reverse aaM phi-mediated inhibition of lymphocyte proliferation. Of several agents interfering with various second messenger pathways, cAMP and the Ca(2+)-ionophore A23187 inhibited differentiation of cultured human monocytes into phenotypically mature aaM phi expressing MS-1 high molecular weight protein (MS-1-HMWP) and RM 3/1 antigen, and prevented the suppressive action of aaM phi on lymphocyte proliferation. In conclusion, these results who that aaM phi actively inhibit mitogen-mediated proliferation of PBL and CD4+ T cells independently of the expression of costimulatory molecules and of IL-10, NO or prostaglandin synthesis, and that inhibition of phenotypic differentiation of aaM phi is paralleled by a lack of functional maturation. Thus, fully matured aaM phi may be functional in down-regulating CD4+ T-cell-mediated immune reactions by an as yet unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9497489      PMCID: PMC1364153          DOI: 10.1046/j.1365-2567.1997.00371.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  79 in total

1.  Inhibition of rat mixed lymphocyte cultures by suppressor macrophages.

Authors:  J R Oehler; R B Herberman; D A Campbell; J Y Djeu
Journal:  Cell Immunol       Date:  1977-03-15       Impact factor: 4.868

Review 2.  Immunological/physiological relationships in asthma: potential regulation by lung macrophages.

Authors:  L W Poulter; G Janossy; C Power; S Sreenan; C Burke
Journal:  Immunol Today       Date:  1994-06

3.  Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines.

Authors:  F O Nestle; L A Turka; B J Nickoloff
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

4.  Suppression of lymphocyte proliferative responses: demonstration of two stages occurring in the in vitro generation of suppressor macrophages.

Authors:  R D Stout; M Fisher
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

5.  T cells involved in psoriasis vulgaris belong to the Th1 subset.

Authors:  J F Schlaak; M Buslau; W Jochum; E Hermann; M Girndt; H Gallati; K H Meyer zum Büschenfelde; B Fleischer
Journal:  J Invest Dermatol       Date:  1994-02       Impact factor: 8.551

6.  The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response.

Authors:  K Uyemura; M Yamamura; D F Fivenson; R L Modlin; B J Nickoloff
Journal:  J Invest Dermatol       Date:  1993-11       Impact factor: 8.551

7.  T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.

Authors:  S Vollmer; A Menssen; P Trommler; D Schendel; J C Prinz
Journal:  Eur J Immunol       Date:  1994-10       Impact factor: 5.532

8.  Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis.

Authors:  Z Szekanecz; G K Haines; T R Lin; L A Harlow; S Goerdt; G Rayan; A E Koch
Journal:  Arthritis Rheum       Date:  1994-02

9.  Induction of hapten-specific tolerance by interleukin 10 in vivo.

Authors:  A H Enk; J Saloga; D Becker; M Mohamadzadeh; J Knop
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  31 in total

1.  Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues.

Authors:  Oliver Politz; Alexei Gratchev; Peter A G McCourt; Kai Schledzewski; Pierre Guillot; Sophie Johansson; Gunbjorg Svineng; Peter Franke; Christoph Kannicht; Julia Kzhyshkowska; Paola Longati; Florian W Velten; Staffan Johansson; Sergij Goerdt
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

2.  Histiocytic sarcoma with two immunohistopathologically distinct populations.

Authors:  Kanako Wakahashi; Manabu Shimoyama; Yoshio Katayama; Kentaro Minagawa; Kenji Yoshida; Ryohei Sasaki; Shunji Nakayama; Hiroshi Yokozaki; Emmy Yanagita; Tomoo Itoh; Yoshitake Hayashi; Toshimitsu Matsui
Journal:  Int J Hematol       Date:  2010-10-06       Impact factor: 2.490

3.  New insights into the multidimensional concept of macrophage ontogeny, activation and function.

Authors:  Florent Ginhoux; Joachim L Schultze; Peter J Murray; Jordi Ochando; Subhra K Biswas
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

4.  Biochemical and functional characterization of three activated macrophage populations.

Authors:  Justin P Edwards; Xia Zhang; Kenneth A Frauwirth; David M Mosser
Journal:  J Leukoc Biol       Date:  2006-08-11       Impact factor: 4.962

Review 5.  Pathogenesis of spondyloarthritis: insights from synovial membrane studies.

Authors:  Leen De Rycke; Elli Kruithof; Bernard Vandooren; Paul P Tak; Dominique Baeten
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 6.  Immune regulation by non-lymphoid cells in transplantation.

Authors:  A-S Dugast; B Vanhove
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

7.  Modeling the immune rheostat of macrophages in the lung in response to infection.

Authors:  Judy Day; Avner Friedman; Larry S Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-22       Impact factor: 11.205

8.  Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis.

Authors:  Alfonso Eirin; Xiang-Yang Zhu; Zilun Li; Behzad Ebrahimi; Xin Zhang; Hui Tang; Michael J Korsmo; Alejandro R Chade; Joseph P Grande; Christopher J Ward; Robert D Simari; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-21       Impact factor: 8.311

9.  Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines.

Authors:  L P Erwig; K Stewart; A J Rees
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

10.  Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model.

Authors:  Cigall Kadoch; Eduard B Dinca; Ramona Voicu; Lingjing Chen; Diana Nguyen; Seema Parikh; Juliana Karrim; Marc A Shuman; Clifford A Lowell; Patrick A Treseler; C David James; James L Rubenstein
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.